Open Access

Establishment and characteristics of GWH04, a new primary human glioblastoma cell line

  • Authors:
    • Fangling Cheng
    • Xueyan Wan
    • Baofeng Wang
    • Youwei Li
    • Peng Peng
    • Sanpeng Xu
    • Chao Han
    • Feng Mao
    • Dongsheng Guo
  • View Affiliations

  • Published online on: September 26, 2022     https://doi.org/10.3892/ijo.2022.5429
  • Article Number: 139
  • Copyright: © Cheng et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Glioblastoma multiforme (GBM) is a common and fatal disease of the central nervous system. GBM cell lines are fundamental tools used in GBM research. The establishment of novel continuous GBM cell lines with clear genetic backgrounds could facilitate the exploration of molecular mechanisms and the screening and evaluation of antitumor drugs in GBM studies. In the present study, a novel primary glioblastoma cell line was established, named GWH04, from a patient with GBM, and its STR genotype and various tumor parameters were examined. The STR information of GWH04 was identical to that of the original primary tumor tissue. Compared with existing cell lines, GWH04 had a similar in vitro proliferation rate as the U87 cell line, but a faster rate than the GL15 cell line, and substantial soft agar clone‑formation capacity and subcutaneous and intracranial tumorigenic capacity. For drug sensitivity test, half maximal inhibitory concentration assays for multiple drugs were performed in these three cell lines, and GWH04 cells were found to be resistant to temozolomide. Aneuploid karyotype with a median of 84 chromosomes was possessed by GWH04, as well as chromosomal structural abnormalities, such as broken chromosomes, double centromere chromosomes, homogeneous staining regions, and double microbodies. Gene sequencing further revealed the mutational status of genes TP53, PTEN, PDGFRA, ERBB2, BRCA1, NF1, and MLH1 and the promoter region of telomerase reverse transcriptase (C228T) in this cell line. Altogether, these results indicated that GWH04 will be a useful tool for human GBM studies both in vitro and in vivo.
View Figures
View References

Related Articles

Journal Cover

November-2022
Volume 61 Issue 5

Print ISSN: 1019-6439
Online ISSN:1791-2423

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Cheng F, Wan X, Wang B, Li Y, Peng P, Xu S, Han C, Mao F and Guo D: Establishment and characteristics of GWH04, a new primary human glioblastoma cell line. Int J Oncol 61: 139, 2022.
APA
Cheng, F., Wan, X., Wang, B., Li, Y., Peng, P., Xu, S. ... Guo, D. (2022). Establishment and characteristics of GWH04, a new primary human glioblastoma cell line. International Journal of Oncology, 61, 139. https://doi.org/10.3892/ijo.2022.5429
MLA
Cheng, F., Wan, X., Wang, B., Li, Y., Peng, P., Xu, S., Han, C., Mao, F., Guo, D."Establishment and characteristics of GWH04, a new primary human glioblastoma cell line". International Journal of Oncology 61.5 (2022): 139.
Chicago
Cheng, F., Wan, X., Wang, B., Li, Y., Peng, P., Xu, S., Han, C., Mao, F., Guo, D."Establishment and characteristics of GWH04, a new primary human glioblastoma cell line". International Journal of Oncology 61, no. 5 (2022): 139. https://doi.org/10.3892/ijo.2022.5429